Contineum Therapeutics, Inc. (CTNM)

NASDAQ: CTNM · IEX Real-Time Price · USD

20.69

-0.31 (-1.48%)

At close: Jul 2, 2024, 4:00 PM

20.29

-0.40 (-1.93%)

After-hours: Jul 2, 2024, 4:57 PM EDT

Contineum Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022
Market Capitalization	532	-	-
Enterprise Value	415	-125	-41
PS Ratio	10.64	-	-
EV/Sales Ratio	8.30	-2.49	-
EV/EBITDA Ratio	-	-25.10	1.83
EV/EBIT Ratio	-	-32.76	1.73
EV/FCF Ratio	-	-6.58	2.05
Debt / Equity Ratio	-0.01	-0.01	-0.06
Debt / EBITDA Ratio	-	0.12	-0.26
Debt / FCF Ratio	-	0.03	-0.29
Quick Ratio	18.91	22.83	6.26
Current Ratio	19.20	23.29	6.41
Asset Turnover	-	0.55	-
Interest Coverage	-	18.29	-61.51
Return on Equity (ROE)	-	-3.90%	-
Return on Assets (ROA)	-	3.50%	-
Return on Capital (ROIC)	-	-20.88%	26.01%
Earnings Yield	-0.08%	-	-
Buyback Yield / Dilution	-51.38%	-
Total Shareholder Return	-51.38%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).